Skip to main content

Find Clinical Trials

Home
Conditions
Hepatitis C

Clinical trial condition

Hepatitis C

Explore clinical trials studying Hepatitis C. Study availability and eligibility vary by location and protocol.

749 public trials 21 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis C trial results

Completed

Filibuvir In Treatment Naive Hepatitis C Virus (HCV) Genotype 1 Subjects

NCT00987337

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Pfizer Investigational Site Anaheim, California, United States

Pfizer Investigational Site Anaheim, California, United States

Pfizer Investigational Site Coronado, California, United States

Pfizer Investigational Site La Jolla, California, United States

View all 77 locations

View Trial Details

Completed

Oxidative Stress and Fatty Acids in Hepatitis C

NCT00444002

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +13 more
Locations: University Health Network (Toronto General Hospital & Toronto Western Hospital) Toronto, Ontario, Canada

View Trial Details

Completed

WEUSKOP5410: Observational Study in ENABLE Clinical Trials

NCT01458080

Conditions: Blood Platelet Disorders, Blood-Borne Infections, Cardiovascular Diseases, +17 more
Locations: Not specified

View Trial Details

Completed

Low-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected With HCV Genotype 2 or 3

NCT00056862

Conditions: Agranulocytosis, Anemia, Anemia, Hemolytic, +21 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Clinical Trial for Non-responders Who Previously Participated in Eltrombopag Studies TPL 103922 or TPL 108390

NCT00996216

Conditions: Blood Platelet Disorders, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: GSK Investigational Site San Diego, California, United States

GSK Investigational Site New Haven, Connecticut, United States

GSK Investigational Site Honolulu, Hawaii, United States

GSK Investigational Site Manhasset, New York, United States

View all 28 locations

View Trial Details

Completed

Clinical Study With Silymarin in the Patients With Chronic Hepatitis C Infection Who Failed Conventional Antiviral Therapy

NCT01258686

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Byung Chul, Yoo Seoul, South Korea

View Trial Details

Completed

Study of the Pharmacokinetics and Safety of Asunaprevir in Patients With Kidney Disease

NCT01886599

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Orlando Clinical Research Center Orlando, Florida, United States

Davita Clinical Research Minneapolis, Minnesota, United States

New Orleans Center For Clinical Research Knoxville, Tennessee, United States

View Trial Details

Completed

A Phase II, Double-blinded, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Vitalliver in Patients With Decompensated Cirrhosis

NCT00562783

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +15 more
Locations: Queen Mary Hospital Hong Kong, China

View Trial Details

Completed

A Study to Investigate the Potential Pharmacokinetic Interaction Between TMC435 and Methadone

NCT00915564

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Toronto, Canada

View Trial Details

Completed

Safety and Efficacy of Telaprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Subjects Co-Infected With Hepatitis C Virus (HCV) and HIV

NCT00983853

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +17 more
Locations: Beverly Hills, California, United States

San Diego, California, United States

San Francisco, California, United States

Miami, Florida, United States

View all 16 locations

View Trial Details